Fröhlich Tony, Çapcı Karagöz Aysun, Reiter Christoph, Tsogoeva Svetlana B
Department of Chemistry and Pharmacy, Organic Chemistry Chair I and Interdisciplinary Center for Molecular Materials (ICMM), University of Erlangen-Nürnberg , Henkestrasse 42, 91054 Erlangen, Germany.
J Med Chem. 2016 Aug 25;59(16):7360-88. doi: 10.1021/acs.jmedchem.5b01380. Epub 2016 Apr 6.
The development of new efficient therapeutics for the treatment of malaria and cancer is an important endeavor. Over the past 15 years, much attention has been paid to the synthesis of dimeric structures, which combine two units of artemisinin, as lead compounds of interest. A wide variety of atemisinin-derived dimers containing different linkers demonstrate improved properties compared to their parent compounds (e.g., circumventing multidrug resistance), making the dimerization concept highly compelling for development of efficient antimalarial and anticancer drugs. The present Perspective highlights recent developments on different types of artemisinin-derived dimers and their structural and functional features. Particular emphasis is put on the respective in vitro and in vivo studies, exploring the role of the length and nature of linkers on the activities of the dimers, and considering the future prospects of the dimerization concept for drug discovery.
开发用于治疗疟疾和癌症的新型高效疗法是一项重要工作。在过去15年里,人们对二聚体结构的合成给予了极大关注,这些二聚体结构将两个青蒿素单元结合在一起,作为感兴趣的先导化合物。与母体化合物相比,各种含有不同连接基的青蒿素衍生二聚体表现出更好的性能(例如,规避多药耐药性),这使得二聚化概念在高效抗疟疾和抗癌药物的开发中极具吸引力。本综述重点介绍了不同类型青蒿素衍生二聚体的最新进展及其结构和功能特点。特别强调了各自的体外和体内研究,探讨连接基的长度和性质对二聚体活性的作用,并考虑二聚化概念在药物发现方面的未来前景。